The Maryland Stem Cell Research Fund has issued a grant to Washington-based Regenerative Orthopedics & Sports Medicine (ROSM) for non-surgical orthopedic research, aimed at advancing treatments for partial-thickness rotator cuff tears using orthobiologic procedures. The two-year randomized, placebo-controlled trial, set to conclude in December 2026, will explore the efficacy of microfat stem cells in treating rotator cuff injuries, an issue that affects more than 2 million Americans annually.
MD Stem Cell Research Fund issues grant to Regenerative Orthopedics & Sports Medicine
October 28, 2024
